Company Name or Ticker Symbol
Search for other Categories

Stemline Therapeutics Inc  (STML)
Other Ticker:  

Cumulative Stemline Therapeutics Inc's Quick Ratio for Trailing Twelve Months Period

STML's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth

STML Quick Ratio for Trailing Twelve Months Period

(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Current Liabilities Growth 35.01 % 6.96 % 19.84 % 31.61 % 48.32 %
Y / Y Cash & cash equivalent Growth 24.97 % 16.21 % 19.85 % 50.02 % 10.99 %
Quick Ratio for Trailing Twelve Months Period 4.31 4.37 4.34 4.34 4.14
Total Ranking # # 413 # 336 # 311 # 327
Seq. Current Liabilities Growth 24.62 % 22.4 % -5.2 % -6.64 % -1.28 %
Seq. Cash & cash equivalent Growth 106.89 % -23.47 % -18.31 % -3.38 % 92.4 %

Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to growth in Current Liabilities in the I. Quarter to $26 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 4.31 below Stemline Therapeutics Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry Stemline Therapeutics Inc achieved highest Quick Ratio for Trailing Twelve Months Period. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to , from total ranking in previous quarter at 413.

What is Quick Ratio?
Learn more about STML
Quick Ratio STML in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0

Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
12.12 5.91 3.72
(Sep. 30, 2015)   (Dec 31 2018)

Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2019, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Vanda Pharmaceuticals Inc.  11.85 
Evolus, Inc.  11.77 
Genprex, Inc.  11.74 
Alpine Immune Sciences, Inc.  11.60 
Adial Pharmaceuticals, Inc.  11.56 
Kala Pharmaceuticals, Inc.  11.56 
Aquinox Pharmaceuticals, Inc  11.26 
Spring Bank Pharmaceuticals, Inc.  11.16 
Mirati Therapeutics, Inc.  11.05 
Biohaven Pharmaceutical Holding Co Ltd.  11.03 
Proqr Therapeutics N.v.  10.49 
Chimerix Inc  10.21 
Five Prime Therapeutics Inc  10.16 
Catalyst Pharmaceuticals, Inc.  10.08 
Cytokinetics Inc  10.00 
Ardelyx, Inc.  9.95 
Pain Therapeutics Inc  9.95 
Blueprint Medicines Corp  9.89 
Alnylam Pharmaceuticals, Inc.  9.78 
Oragenics Inc  9.78 
Kindred Biosciences, Inc.  9.57 
Revance Therapeutics, Inc.  9.46 
Flexion Therapeutics Inc  9.32 
Aeglea Biotherapeutics, Inc.  9.24 
Abeona Therapeutics Inc.  9.21 
Millendo Therapeutics, Inc.  9.20 
Insmed Inc  9.12 
Sarepta Therapeutics, Inc.  9.04 
Epizyme, Inc.  8.98 
Zafgen, Inc.  8.86 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

EA's Profile

Stock Price

EA's Financials

Business Description


Charts & Quotes

EA's News


EA's Competitors

Customers & Markets

Economic Indicators

EA's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071